Novel insights in the diagnosis of Cushing's syndrome

Neuroendocrinology

Volumn 92, Issue SUPPL. 1, 2010, Pages 35-43

  Alexandraki, Krystallenia I ^a   Grossman, Ashley B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bed time salivary cortisol; Cushing's syndrome; Dexamethasone suppression test; Late night salivary cortisol; Midnight serum cortisol; Salivary cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CONFERENCE PAPER; CORRELATION ANALYSIS; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONAL REGULATION; HORMONE RESISTANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SALIVA LEVEL;

CIRCADIAN RHYTHM; CUSHING SYNDROME; HUMANS; HYDROCORTISONE; SALIVA;

EID: 77956529776     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314295     Document Type: Conference Paper

References (77)

1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK: Cushing's syndrome. Lancet 2006; 367:1605-1617.
2. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin En-docrinol Metab 2009; 94: 2692-2701.
3. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ: Pre-clinical Cush-ing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 1996; 44: 717-722.
4. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202.
5. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A: Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 2003; 88: 5808-5813.
6. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W: Preclinical Cush-ing's syndrome in adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992; 75: 826-832.
7. Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB: How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf) 2000; 53: 493-500.
8. Alexandraki KI, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL, Monson JP, Besser GM, Grossman AB: The prevalence and characteristic features of cyclicity and variability in Cushing's disease. Eur J Endo-crinol 2009; 160:1011-1018.
9. Meinardi JR, Wolffenbuttel BH, Dullaart RP: Cyclic Cushing's syndrome: a clinical challenge. Eur J Endocrinol 2007; 157:245-254.
10. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540.
11. Etxabe J, Vazquez JA: Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994; 40: 479-484.
12. Yanovski JA, Cutler GB Jr, Chrousos GP, Nie-man LK: The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. J Clin Endo-crinol Metab 1998; 83:348-352.
13. Martin NM, Dhillo WS, Banerjee A, Abdu-lali A, Jayasena CN, Donaldson M, Todd JF, Meeran K: Comparison of the dexa-methasone-suppressed corticotropin-releas-ing hormone test and low-dose dexametha-sone suppression test in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2006; 91:2582-2586.
14. Vilar L, Freitas Mda C, Faria M, Montenegro R, Casulari LA, Naves L, Bruno OD: Pitfalls in the diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol 2007; 51: 1207-1216.
15. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B: Evidence for the low dose dexa-methasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34: 222-229.
16. Kaltsas GA, Isidori AM, Skelly RH, Kola B, Monson JP, Grossman AB, Besser GM: The value of the low dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endo-crinol Metab 2003; 88: 2634-2643.
17. Kidambi S, Raff H, Findling JW: Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol 2007; 157:725-731.
18. Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK: A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1163-1167.
19. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M: A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1995; 43:545-550.
20. Dunn JF, Nisula BC, Rodbard D: Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 58-68.
21. Brien TG: Human corticosteroid binding globulin. Clin Endocrinol (Oxf) 1981; 14: 193-212.
22. Kahn JP, Rubinow DR, Davis CL, Kling M, Post RM: Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry 1988; 23: 335-349.
23. Raff H, Raff JL, Findling JW: Late-night salivary cortisol as a screening test for Cush-ing's syndrome. J Clin Endocrinol Metab 1998; 83:2681-2686.
24. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Müller B: Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexa-methasone suppression test. J Clin Endocri-nol Metab 2005; 90:5730-5736.
25. Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN: Diagnostic value of salivary cortisol in Cushing's syndrome (CS). Clin Endocrinol (Oxf) 2009; 70: 516-5 21.
26. Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A: Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 2009; 94: 456-462.
27. Vining RF, McGinley RA, Maksvytis JJ, Ho KY: Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem 1983; 20:329-335.
28. Chen YM, Cintrón NM, Whitson PA: Long-term storage of salivary cortisol samples at room temperature. Clin Chem 1992; 38: 304.
29. Hiramatsu R: Direct assay of cortisol in human saliva by solid phase radioimmunoas-say and its clinical applications. Clin Chim Acta 1981; 117: 239-249.
30. Raff H, Homar PJ, Burns EA: Comparison of two methods for measuring salivary cortisol. Clin Chem 2002; 48:207-208.
31. Baid SK, Sinaii N, Wade M, Rubino D, Nie-man LK: Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin En-docrinol Metab 2007; 92:3102-3107.
32. Trilck M, Flitsch J, Lüdecke DK, Jung R, Pe-tersenn S: Salivary cortisol measurement-a reliable method for the diagnosis of Cush-ing's syndrome. Exp Clin Endocrinol Diabetes 2005; 113:225-230.
33. Liu H, Bravata DM, Cabaccan J, Raff H, Ry-zen E: Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) 2005; 63:642-649.
34. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC: Out-patient screening for Cush-ing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary corti-sol tests. J Clin Endocrinol Metab 1999; 84: 878-882.
35. Papanicolaou DA, Mullen N, Kyrou I, Nie-man LK: Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2002; 87: 4515-4521.
36. Friedman TC, Zuckerbraun E, Lee ML, Kabil MS, Shahinian H: Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup. Horm Metab Res 2007; 39:451-456.
37. Laud at MH, C erdas S, Four nier C, Gu iban D, Guilhaume B, Luton JP: Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocri-nol Metab 1988; 66:343-348.
38. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM: Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 2008; 93: 1553-1562.
39. Carroll T, Raff H, Findling JW: Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 2009; 15:335-342.
40. Putignano P, Toja P, Dubini A, Pecori Giral-di F, Corsello SM, Cavagnini F: Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab 20 03; 88: 4153-4157.
41. Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X: Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 2004; 89:3345-3351.
42. Raff H: Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab 2009; 94: 3647-3655.
43. Bewick V, Cheek L, Ball J: Statistics review 13: receiver operating characteristic curves. Crit Care 2004; 8: 508-512.
44. Kahn SE, Maxwell JU, Barron JL: Salivary cortisol assessment in the evaluation of hypothalamic-pituitary-adrenal function. S Afr Med J 1984; 65:843-846.
45. Bonnin R, Villabona C, Rivera A, Guillen E, Sagarra E, Soler J, Navarro MA: Is salivary cortisol a better index than free cortisol in serum or urine for diagnosis of Cushing syndrome? Clin Chem 1993; 39: 1353-1354.
46. Hägg E, Olsson T, Grank v ist K: S a l iva r y cor-tisol during an overnight dexamethasone suppression test using a simple saliva collection device. Horm Metab Res 1990; 22:553-554.
47. Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP, Thomopoulos P: Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome. Eur J Endocrinol 1996; 134: 93-96.
48. Martinelli CE Jr, Sader SL, Oliveira EB, Dan-eluzzi JC, Moreira AC: Salivary cortisol for screening of Cushing's syndrome in children. Clin Endocrinol (Oxf) 1999; 51: 67-71.
49. Castro M, Elias LL, Elias PC, Moreira AC: A dose-response study of salivary cortisol after dexamethasone suppression test in Cush-ing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Ox f) 2003; 59: 800-805.
50. Cope ClL Black EG: The reliability of some adrenal function tests. Br Med J 1959;ii:1117-1122.
51. Flack MR, Oldfield EH, Cutler GB Jr, Zweig MH, Malley JD, Chrousos GP, Loriaux DL, Nieman LK: Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 1992; 116:211-217.
52. Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N: Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin Biochem 2008; 41: 688-692.
53. Gafni RI, Papanicolaou DA, Nieman LK: Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents. J Pediatr 2000; 137: 30-35.
54. Masserini B, Morelli V, Bergamaschi S, Er-metici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodi ni I: The l i mited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocri-nol 2009; 160: 87-92.
55. Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshi-moto T, Hi rata Y: Late-night sa l iva r y cor tisol as a screening test for the diagnosis of Cush-ing's syndrome in Japan. Endocr J 2008; 55: 121-126.
56. Hermus AR, Pieters GF, Borm GF, Verhofs-tad AA, Smals AG, Benraad TJ, Kloppenborg PW: Unpredictable hypersecretion of corti-sol in Cushing's disease: detection by daily salivary cortisol measurements. Acta Endo-crinol (Copenh) 1993; 128: 428-432.
57. Myhill PC, Sillars BA, Starkstein S, Annus T, Yeap BB: Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome. J Neuropsy-chiatry Clin Neurosci 2008; 20:113-115.
58. Issa BG, Page MD, Read G, John R, Douglas-Jones A, Scanlon MF: Undetectable urinary free cortisol concentrations in a case of Cushing's disease. Eur J Endocrinol 1999; 14 0: 148-151.
59. Mosnier-Pudar H, Thomopoulos P, Bertag-na X, Fou rnier C, Gu iban D, Luton JP: Longdistance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements. Eur J Endocri-nol 1995; 133: 31 3-316.
60. Poll EM, Kreitschmann-Andermahr I, Lan-gejuergen Y, Stanzel S, Gilsbach JM, Gress-ner A, Yagmur E: Saliva collection method affects predictability of serum cortisol. Clin Chim Acta 2007; 382:15-19.
61. Kidd S, Midgley P, Lone N, Wallace AM, Ni-col M, Smith J, McIntosh N: A re-investigation of saliva collection procedures that highlights the risk of potential positive interference in cortisol immunoassay. Steroids 2009; 74: 666-668.
62. Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K, Kro-zowski ZS: Localization of 11 beta-hydroxy-steroid dehydrogenase type II in human epithelial tissues. J Clin Endocrinol Metab 1996; 81: 324 4-3248.
63. Badrick E, Bobak M, Britton A, Kirschbaum C, Marmot M, Kumari M: The relationship between alcohol consumption and cortisol secretion in an aging cohort. J Clin Endocri-nol Metab 2008; 93: 750-757.
64. Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA: Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 2004; 46: 39-4 6.
65. Guechot J, Fiet J, Passa P, Villette JM, Gour-mel B, Tabuteau F, Cathelineau G, Dreux C: Physiological and pathological variations in saliva cortisol. Horm Res 1982; 16:357-364.
66. Garde AH, Persson R, Hansen AM, Oster-berg K, Ørbaek P, Eek F, Karlson B: Effects of lifestyle factors on concentrations of salivary cortisol in healthy individuals. Scand J Clin Lab Invest 2009; 69: 242-250.
67. Dennis PM: The determination of free plasma cor tisol. N Z Med J 1963; 62: 478-481.
68. Kley HK, Bartmann E, Krüskemper HL: A simple and rapid method to measure non-protein-bound fractions of cortisol, testosterone and oestradiol by equilibrium dialysis: comparison with centrifugal filtration. Acta Endocrinol (Copenh) 1977; 85: 209-219.
69. Friedman TC, Yanovski JA: Morning plasma free cortisol: inability to distinguish patients with mild Cushing syndrome from patients with pseudo-Cushing states. J Endocrinol Invest 1995; 18: 696-701.
70. Le Roux CW, Chapman GA, Kong WM, Dhil-lo WS, Jones J, Alaghband-Zadeh J: Free cor-tisol index is better than serum total cortisol in determining hypothalamic-pituitary-ad-renal status in patients undergoing surgery. J Clin Endocrinol Metab 2003; 88:2045-2048.
71. Watanobe H, Nigawara T, Nasushita R, Sa-sa k i S, Ta kebe K: A c a se of cycl ica l Cu sh i ng's disease associated with corticosteroid-bind-ing globulin deficiency: a rare pitfall in the diagnosis of Cushing's disease. Eur J Endo-crinol 1995; 133: 317-319.
72. Allolio B, Hoffmann J, Linton EA, Winkel-mann W, Kusche M, Schulte HM: Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin En-docrinol (Oxf) 1990; 33: 279-289.
73. Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ: The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta 1987; 165: 379-385.
74. Alexandraki KI, Kaltsas GA, le Roux CW, Fassnacht M, Ajodha S, Christ-Cra in M, A k-ker SA, Drake WM, Edwards R, Allolio B, Grossman AB: Assessment of serum free cortisol levels in patients with adrenocorti-cal carcinoma treated with mitotane: a pilot study. Clin Endocrinol (Oxf) 2010;72:305-311.
75. Van Seters AP, Moolenaar AJ: Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol (Copenh) 1991; 124:526-533.
76. Caetano MS, Silva Rdo C, Kater CE: Increased diagnostic probability of subclinical Cushing's syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol 2007; 51: 1118-112 7.
77. Vilar L, Freitas MC, Naves LA, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Ar-ruda MJ, Silva LM, Arahata CM, Agra R, Lima LH, Azevedo M, Casulari LA: The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome. J Endocrinol Invest 2008; 31:1008-1013.